Quick Summary
Sutobuzz 25mg Capsule
Last updated on 08 Jun 2026 | 07:27 AM (IST)
₹950
MRP: ₹2110
(You Save ₹1160)
28 CAPSULE(s) IN A BOTTLE
55% OFF
₹950
MRP: ₹2,110.00
Inclusive of all taxes
55% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Sutenamo 25mg Capsule
SHIVNAAM TRADEL...
₹ 67.82/capsule
100% costlier
Sunitcap 25mg Capsule
Allieva Pharma ...
₹ 82.14/capsule
143% costlier
Sukinsa 25mg Capsule
HALSTED PHARMA ...
₹ 88.00/capsule
160% costlier
Adsunib 25mg Capsule
ADLEY FORMULATI...
₹ 93.43/capsule
176% costlier
Introduction
Sutobuzz 25mg Capsule consists of the active ingredient Sunitinib. Sutobuzz 25 mg capsule belongs to a class of medicines called tyrosine kinase inhibitors, which work by blocking specific enzymes involved in the growth and spread of cancer cells. Sutobuzz 25mg Capsule uses include the treatment of gastrointestinal stromal tumors (GIST), advanced kidney cancer, and pancreatic neuroendocrine tumors (PNET).
Sutobuzz 25 is commonly prescribed for cancers that continue to grow or spread despite other treatments. The benefits of Sutobuzz 25mg Capsule include slowing cancer progression, reducing tumor growth, and helping improve disease control in certain cancer patients. The dosage of Sutobuzz 25mg Capsule depends on the type of cancer, body condition, and physician recommendation. Patients looking to buy Sutobuzz 25mg Capsule should use a valid prescription and purchase only from trusted pharmacies. The price of Sutobuzz 25mg Capsule may vary depending on the brand, pack size, and pharmacy location.
Before taking this medicine, inform your doctor if you have blood disorders, heart problems, liver disease, kidney disorders, diabetes, seizures, skin disorders, or thyroid problems. Also tell your healthcare provider if you recently had surgery or are planning surgery. Patients with high blood pressure should be monitored carefully because Sutobuzz 25mg Capsule may sometimes cause hypertension as a side effect.
Avoid consuming grapefruit or grapefruit juice during treatment because it may interfere with the effectiveness of the medicine. Consult your dentist before starting treatment if you have mouth pain, swelling, sores, or other dental problems. Sutobuzz 25mg Capsule side effects may include fatigue, nausea, diarrhea, mouth sores, high blood pressure, skin discoloration, weakness, loss of appetite, and changes in taste. It is generally not recommended for individuals below 18 years of age unless specifically advised by a physician.
Uses
Sutobuzz 25mg Capsule is used in the treatment of the following condition:
Renal cell carcinoma (RCC)
Gastrointestinal stromal tumors (GIST)
Pancreatic neuroendocrine tumors (PNET)
Medullary thyroid cancer
Certain kidney cancer
How Sutobuzz 25mg Capsule Works
The therapeutic effects of Sutobuzz 25mg Capsule include slowing down or stopping the growth and spread of cancer cells in the body, thereby reducing the size and number of tumors. It works by inhibiting the activity of specific proteins known as tyrosine kinases, which are involved in the signaling pathways that control cell growth and division. It can help to prevent cancer cells from growing and spreading by blocking these pathways.
Interaction of Sutobuzz 25mg Capsule with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Sutobuzz 25mg Capsule and reduce its effectiveness by causing undesirable side effects.
Storage Conditions
Sutobuzz 25mg Capsule should be stored at room temperature, between 68°F and 77°F (20°C and 25°C).
Keep it in the original package.
Protected from moisture, light, and heat.
Keep it out of reach from children and pets.
How to take Sutobuzz 25mg Capsule
Sutobuzz 25mg Capsule is taken orally, in the form of capsules, with a glass of water. The capsules should be swallowed whole and not crushed, chewed, or opened. The recommended dose may vary depending on the type of cancer being treated, the patient's age and weight, and other factors. This medication is usually taken once a day, with or without food, at around the same time each day. If you miss a dose then do not double the dose to compensate for the missed dose.
Safety advice
Pregnancy
Sutobuzz 25mg Capsule is unsafe for a developing fetus and is not recommended during pregnancy as it can cause harm to the developing fetus.
Breast Feeding
It is unknown whether Sutobuzz 25mg Capsule is excreted in human breast milk. Breastfeeding women should discuss the potential risks and benefits of the medication with their healthcare provider before starting treatment.
Lungs
Sutobuzz 25mg Capsule can cause interstitial lung disease (ILD), a serious and potentially fatal condition that causes scarring of the lungs. Patients taking this medication should be monitored for symptoms of ILD, such as cough, shortness of breath, and fever, and treatment should be interrupted or discontinued if necessary.
Liver
Sutobuzz 25mg Capsule can cause liver toxicity, which can be severe or fatal in some cases. Patients taking this medication should have their liver function tests done regularly, and treatment should be interrupted or discontinued if these tests are abnormal.
Alcohol
It is generally recommended to avoid consuming alcohol during treatment with anticancer medication, as alcohol can potentially interfere with the effectiveness of the medication and increases the liver-related and other potential side effects.
Driving
Patients receiving Sutobuzz 25mg Capsule are advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Side effects related to Sutobuzz 25mg Capsule are as follows:
Serious:
Heart failure or heart attack
Elevated liver function tests.
Liver failure
Proteinuria
Acute kidney injury
Interstitial lung disease (inflammation of lung walls)
Pulmonary arterial hypertension
Gastrointestinal perforation or fistula
Haemorrhage (bleeding)
Hypothyroidism (low thyroid function)
Hypoglycemia (low blood sugar)
Common
Fatigue
Nausea and vomiting
Diarrhoea
Loss of appetite
Hand-foot syndrome
Skin discoloration or rash
High blood pressure
Headache
Hair loss
Changes in taste
Dry skin or itching
Nosebleeds
Expert Tips
If you have been prescribed Sutobuzz 25mg Capsule, it is important to follow your healthcare provider's instructions. During treatment avoid taking grapefruit or grapefruit juice as it can increase the levels of medication in the blood and potentially increase the risk of side effects. Use a reliable method of birth control while taking the medication and for at least four weeks after the last dose.
This medication can cause serious side effects, so it is important to be vigilant and informed about your treatment. Make sure to report any symptoms or changes in your health, even if they seem minor. With proper precautions and monitoring, it can be an effective treatment for certain types of cancer.
FAQs
Q1.
Can Sutobuzz 25mg Capsule cause changes in skin color?
Yes, Sutobuzz 25mg Capsule can cause changes in skin color. One common side effect is called "hand-foot syndrome," which can cause redness, swelling, and pain in the palms of the hands and soles of the feet. In some cases, this syndrome can also cause the skin to darken or become thickened in these areas. Additionally, this medication can cause other skin changes, such as rashes and discoloration.
Q2.
Can Sutobuzz 25mg Capsule cause heart problems?
Yes, Sutobuzz 25mg Capsule can cause heart problems such as high blood pressure, heart failure, and heart attack. Patients taking this medication should be closely monitored by their healthcare provider for any signs of heart problems and may need to undergo regular heart function tests.
Q3.
Can Sutobuzz 25mg Capsule cause kidney problems?
Yes, Sutobuzz 25mg Capsule can cause kidney problems such as proteinuria (excess protein in the urine) and renal impairment. Patients taking this medication require regular monitoring of kidney function and need to adjust the dosage or switch to a different medication if these side effects occur or persist.
Q4.
Can I take Sutobuzz 25mg Capsule if I have a thyroid problem?
Yes, but your healthcare provider will monitor your thyroid function regularly. Sutobuzz 25mg Capsules can affect the thyroid gland, causing hypothyroidism (an underactive thyroid gland) or hyperthyroidism (an overactive thyroid gland). Therefore, your healthcare provider will check thyroid hormone levels in blood before starting treatment, and periodically during treatment.
Q5.
Can Sutobuzz 25mg Capsule affect fertility?
Yes, Sutobuzz 25mg Capsules can affect fertility in both men and women. Patients taking this medication should discuss the potential risks and options for preserving fertility with their healthcare provider before starting treatment.
Q6.
How can Sutobuzz 25mg Capsule affect my blood?
Sutobuzz 25mg Capsules can cause hematologic toxicity, which may include neutropenia (low white blood cell count), thrombocytopenia (low platelet count), and anemia (low red blood cell count). These changes can increase the risk of infection, bleeding, and fatigue, respectively.
Fact Box
Molecule name | Sunitinib |
Therapeutic class | Anticancer |
Pharmacological class | Tyrosine kinase inhibitor |
Indications | 1. Renal cell carcinoma (RCC) 2. Gastrointestinal stromal tumours (GIST) 3. Pancreatic neuroendocrine tumours (PNET) 4. Medullary thyroid cancer 5. Certain kidney cancer |
References
Pfizer, U.S Drug and food safety administration (FDA), [Revised on Dec 2018], [Accessed on 5th April 2023],
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021938s035lbl.pdfAnton Wellstein, Giuseppe Giaccone, Michael B. Atkins, and Edward A. Sausville, Pathway-Targeted Therapies: Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules, Goodman & Gilman’s Pharmacological Basis of Therapeutics, 13th Edition, 2018, 1203-1236.
Robert J. Thomson; Majid Moshirfar; Yasmyne Ronquillo, Tyrosine Kinase Inhibitors, [Revised on 21st Jan 2021] [Accessed on 5th April 2023],
https://www.ncbi.nlm.nih.gov/books/NBK563322/Pfizer, Electronic Medicines Compendium (EMC) [Revised on Mar 2021] [Accessed on 5th April 2023], https://www.medicines.org.uk/emc/files/pil.7966.pdf
KD Tripathi, Anticancer Drugs, Essentials of Medical Pharmacology, 8th Edition, 2019, 915-936
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Vikas B S
Pharm D
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 08 Jun 2026 | 07:27 AM (IST)
Want to know more?
Read Our Editorial Policy
